(E)-6-(2-((1-(4-(furan-2-yl)phenyl)-4-methyl-1H-imidazol-5-yl)methyl)phenoxy)-4-methylhex-4-enoic acid

ID: ALA4753405

Chembl Id: CHEMBL4753405

PubChem CID: 162653746

Max Phase: Preclinical

Molecular Formula: C28H28N2O4

Molecular Weight: 456.54

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  C/C(=C\COc1ccccc1Cc1c(C)ncn1-c1ccc(-c2ccco2)cc1)CCC(=O)O

Standard InChI:  InChI=1S/C28H28N2O4/c1-20(9-14-28(31)32)15-17-34-27-7-4-3-6-23(27)18-25-21(2)29-19-30(25)24-12-10-22(11-13-24)26-8-5-16-33-26/h3-8,10-13,15-16,19H,9,14,17-18H2,1-2H3,(H,31,32)/b20-15+

Standard InChI Key:  YDUVHHWWVOQIFU-HMMYKYKNSA-N

Alternative Forms

1. Parent:

   

   ALA4753405

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 456.54

Molecular Weight (Monoisotopic): 456.2049

AlogP: 6.22

#Rotatable Bonds: 10

Polar Surface Area: 77.49

Molecular Species: ACID

HBA: 5

HBD: 1

#RO5 Violations: 1

HBA (Lipinski): 6

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 4.16

CX Basic pKa: 6.06

CX LogP: 4.00

CX LogD: 2.69

Aromatic Rings: 4

Heavy Atoms: 34

QED Weighted: 0.29

Np Likeness Score: -0.25

References

1. Lagu B,Kluge AF,Tozzo E,Fredenburg R,Bell EL,Goddeeris MM,Dwyer P,Basinski A,Senaiar RS,Jaleel M,Tiwari NK,Panigrahi SK,Krishnamurthy NR,Takahashi T,Patane MA.  (2018)  Selective PPARδ Modulators Improve Mitochondrial Function: Potential Treatment for Duchenne Muscular Dystrophy (DMD).,  9  (9.0): [PMID:30258544] [10.1021/acsmedchemlett.8b00287]

Source

Source(1):

• Scientific Literature